IBEX Ltd (IBEX)


IBEX Ltd (NASDAQ-IBEX) is a NASDAQ-listed common stock security of IBEX Ltd in the industrials sector and professional services industry. The company’s business centers on outsourced customer experience and support work for clients that need help managing customer contacts and related service functions. Its offerings are organized around customer service, technical support, customer acquisition, and other back-office tasks delivered through digital and voice-based channels. As a common equity security, IBEX represents an ownership interest in the company rather than a separate fund, debt instrument, or depositary receipt. Investors may use the listing to follow the company’s market performance and public disclosures.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-IBEX
$45.26
30.7% Upside
Undervalued
$37.50
8.3% Upside
Fair
Great
0.0%
September 10, 2026
9.8x
2.9x
0.7x
469.6 M
510.2 M
11.5%
81.3%
5.6
68.5%
Valuation • Fair Value

IBEX Ltd (NASDAQ-IBEX) Fair Value by Valuation Model

Compare the primary fair value estimate for IBEX Ltd (NASDAQ-IBEX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$45.26

Estimated upside of 30.7% versus the current market price.

Fair Value Confidence

High

Confidence level for the primary fair value estimate.

DCF Fair Value

$53.54

Discounted cash flow valuation reference.

Ben Graham Formula Value

$39.10

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$39.90

Earnings power value estimate.

Comps Fair Value

$37.87

Comparable-company valuation reference.

Analyst Price Target

$37.50

Analysts imply upside of 8.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for IBEX Ltd (NASDAQ-IBEX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for IBEX Ltd (NASDAQ-IBEX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

626.9 M

Current operating scale indicator.

Revenue Forecast

639.8 M

Forward revenue estimate.

EBITDA

77.95 M

Current operating profitability reference.

EBITDA Forecast

83.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review IBEX Ltd (NASDAQ-IBEX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for IBEX Ltd (NASDAQ-IBEX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.50

No elevated caution signal from this screen.

Altman Z-Score

5.6

Relatively strong balance-sheet zone.

FCF / Net Income

68.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for IBEX Ltd (NASDAQ-IBEX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for IBEX Ltd (NASDAQ-IBEX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

September 10, 2026

Days to Earnings

51

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for IBEX Ltd (NASDAQ-IBEX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

IBEX Ltd (NASDAQ-IBEX) Stock Forecast & Technical Outlook

Review IBEX Ltd (NASDAQ-IBEX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for IBEX Ltd (NASDAQ-IBEX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for IBEX Ltd (NASDAQ-IBEX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for IBEX Ltd (NASDAQ-IBEX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for IBEX Ltd (NASDAQ-IBEX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for IBEX Ltd (NASDAQ-IBEX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for IBEX Ltd (NASDAQ-IBEX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, IBEX Ltd (NASDAQ-IBEX) has a Hold consensus, with 0 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 0
Hold 2
Sell 0
FAQ Fast Investor Answers

IBEX Ltd (NASDAQ-IBEX) Stock FAQ

Quick answers about IBEX Ltd (NASDAQ-IBEX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$45.26
Estimated upside 30.7%
Valuation Rating
Undervalued
Estimated upside of 30.7%
Analyst Target
$37.50
Implied upside 8.3%
Financial Health
Great
Current financial-health read

The current fair value estimate for IBEX Ltd (NASDAQ-IBEX) is $45.26. This implies an estimated upside of 30.7% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 30.7% versus the current market price.

The available analyst price target for IBEX Ltd (NASDAQ-IBEX) is $37.50. The analyst target implies estimated upside of 8.3%.

The current financial health read for IBEX Ltd (NASDAQ-IBEX) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for IBEX Ltd (NASDAQ-IBEX) is September 10, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for IBEX Ltd (NASDAQ-IBEX) is 9.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for IBEX Ltd is 469.6 M.

The current enterprise value listed for IBEX Ltd is 510.2 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for IBEX Ltd is NASDAQ-IBEX, and the stock is listed on NASDAQ.

IBEX Ltd (NASDAQ-IBEX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for IBEX Ltd is 11.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for IBEX Ltd is 81.3%. Free float helps investors understand how much of the share base is available for public trading.